Treatment of Patients With COVID-19 With Convalescent Plasma (COOPCOVID-19)

NCT04415086 PHASE2 COMPLETED

The COVID-19 pandemic has been spreading continuously, and in Brazil, until May 31, 2020, there have been more than 450.000 cases with more than 28.000 deaths, with daily increases. The present study proposes to evaluate the efficacy and safety of convalescent plasma in treatment of severe cases of COVID-19 in a multicenter, randomized, open-label and controlled study

Details

Lead sponsor	University of Sao Paulo General Hospital
Phase	PHASE2
Status	COMPLETED
Enrolment	129
Start date	Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• COVID-19

Interventions

• convalescent plasma

Countries

Brazil